The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
D001241:Aspirin / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D012107:Research Design; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D001241:Aspirin; D013442:Sulfinpyrazone